Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Medically reviewed by Beth Thomas, PharmD Fact checked by Nick Blackmer N-acetylcysteine (NAC) supplements are proposed to ...

The major findings of this study of exacerbations of COPD can be summarised as follows: (a) among patients with elevated CRP, those receiving NAC were more likely to have this marker normalised ...